DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)

Market Cap	21.06B +10.8%
Revenue (ttm)	27.52B +3.1%
Net Income	1.29B +31.8%
EPS	1.13 +30.8%
Shares Out	1.14B
PE Ratio	16.39
Forward PE	15.40
Dividend	0.68 (3.64%)
Ex-Dividend Date	n/a

Volume	6,467,625
Average Volume	6,390,635
Open	18.48
Previous Close	18.49
Day's Range	18.32 - 18.89
52-Week Range	15.50 - 21.78
Beta	0.62
RSI	54.86
Earnings Date	Apr 24, 2026

About SHA:603233

DaShenLin Pharmaceutical Group Co., Ltd. manufactures, distributes, and retails pharmaceutical products in China. It offers Chinese and Western patent medicines, ginseng and antler tonic medicinal materials, Chinese herbal medicine slices, health products, medical devices, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1999
• Employees: 43,532
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603233

Financial Performance

In 2025, SHA:603233's revenue was 27.50 billion, an increase of 3.80% compared to the previous year's 26.50 billion. Earnings were 1.24 billion, an increase of 35.04%.